- Janus Henderson cuts Ströer voting rights stake to 0% from 3.02%
- Pelthos Therapeutics posts investor deck outlining dermatology portfolio strategy centered on Zelsuvmi launch, Xepi and Xeglyze additions
- Bitcoin Well Q2 FY26 net loss narrows to $38,068; revenue falls 43% to $18.5 million
- Ashley Gold submits final Phase II Tak drilling holes for fire assay, sends Phase III TAK-26-16 to lab
- Grace Therapeutics FY27 Q1 net loss widens to $15.79 million; operating loss widens to $15.92 million
- NovaRed confirms 42-hectare chargeability target at Wilmac copper-gold project in British Columbia
- Goldera Exploration subscribes for 2,500,000 Gold Orogen units for CDN$ 200,000
- Clean Motion directs issue of 8,454,087 units to Vator Securities at SEK 0.1 each
- Evolution PowerX Q2 FY26 adjusted EBITDA more than doubles to $2.11 million; revenue rises 36% to $8.83 million
- Advanced Flower Capital Q2 net investment income rises 8% to $3.48 million; total investment income increases 8% to $8.69 million
- Reborn Coffee signs agricultural products supply deal worth at least $20 million annually with Mighty Oak
- GDS swings to Q2 FY26 net profit of RMB 837.6 million; revenue rises 6.5% to RMB 3.09 billion
- Great Pacific Gold expands Wild Dog project after 9 m channel sample grades 4.81 g/t gold at Elamaraka vein system
- EDM Resources gains DTC eligibility for US electronic trade settlement
- Bragg Gaming says 2Q26 revenue falls 12% on Netherlands legacy contract roll-off, other market softness
- Bravada Gold appoints Zach Allwright to board in governance reshuffle
- Yesway Q2 FY26 net income rises 22.73% to $29.7 million; adjusted EBITDA climbs 35% to $70.9 million
- Silver North continues Haldane drilling, completes 10 holes in Yukon program
- CorMedix Q2 2026 net income rises 31.1% to $26 million; revenue more than doubled to $101.9 million
- Janus Henderson Group cuts Ströer stake to 0% from 3.02%
- Cabaletta Bio Q2 FY26 net loss narrows 11.69% to $51.02 million; R&D expenses rise 18.06% to $44.43 million
- SALESFORCE, INC. <CRM.N>: MONNESS CRESPI HARDT RAISES TARGET PRICE TO $222 FROM $200
- ADC Therapeutics Q2 FY26 net loss narrows 70.75% to $16.6 million; revenue rises 2.99% to $19.25 million
- Intuitive Machines Q2 FY26 net loss narrows to $62.84 million; revenue more than quadruples to $206.17 million vs Q2 FY25
- Falcon’s Beyond Global Q2 FY26 net loss swings to USD 318,000; revenue more than doubled to USD 5.62 million
- Creative Realities FY26 Q2 net loss widens to $4.3 million; revenue rises to $21.5 million
- Ascendis Pharma Q2 FY26 swings to net profit of €207 million; revenue more than doubles to €339 million
- Karyopharm Q2 FY26 net loss widens to $67 million; revenue falls 11.85% to $33.4 million
- Clean Motion makes private placement of 8,454,087 units to Vator Securities at SEK 0.10 each
- MiNK Therapeutics Q2 FY26 net loss narrows to $3.13 million; cash falls to $8.81 million
- Wabash National amends credit agreement for USD 300 million revolving facility
- Triton International posts investor presentation highlighting container leasing demand, cash flow and investment-grade capital structure
- Abeona Q2 FY26 net loss widens to $20.2 million; revenue rises 31% Q/Q to $11.4 million
- Cocrystal Pharma Q2 FY26 net loss widens to $3.16 million; R&D expense climbs to $2.14 million
- Auxly Q2 FY26 net income falls 7% to $7.7 million; net revenue rises 18% to $45.8 million
- FitLife Brands FY26 Q2 net income rises 12% to $2 million; revenue climbs 65% to $26.5 million
- Bragg Gaming FY26 Q2 net loss widens to EUR 2.88 million; revenue drops 12% to EUR 22.9 million
- NervGen Q2 FY26 net loss widens to C$29.2 million
- GLOBAL MARKETS-Stocks rise with oil price below $90, euro edges up, Iran in focus
- BRIEF-Karyopharm Therapeutics Q2 Net Income USD -67.023 Million
- BRIEF-InPlay Oil Q2 Revenue CAD 124.1 Million
- Abeona Therapeutics 2Q Loss/Shr 35c >ABEO
- FitLife Brands 2Q EPS 20c >FTLF
- Cabaletta Bio 2Q Loss/Shr 34c >CABA
- Bridgemarq Real Estate 2Q Loss/Shr C$0.13 >BRE.T
- Boston Pizza Fund 2Q Rev C$13.6M >BPF.UN.T
- Novus raises Mustek beneficial stake to 56.86%
- Skjern Bank H1 pretax profit rises 6.3% to DKK 179.3 million year-on-year
- Vertical Aerospace Q2 FY26 net loss widens to GBP 42.13 million; operating loss rises to GBP 41.45 million
- First Berlin reiterates Buy on Grand City Properties, keeps target at EUR 14.8
- Banrisul publishes 2Q26 results presentation factsheet
- New Toyo sells Jing Cheng Beijing Duck Restaurant unit for USD 605,000
- Vertical Aerospace seeks up to £10 million UK government support for production facility expansion
- Banrisul fiscal council backs H1 2026 financial statements, cites clean KPMG reports
- PBG adjusted recurring EBITDA slips 3.9% to R$ 97.1 million in 2Q26; net loss widens to R$ 62.7 million
- Kepler Weber posts 2Q26 net income of R$ 6.3 million
- EXCHANGE INCOME CORP <EIF.TO>: RAYMOND JAMES RAISES TARGET PRICE TO C$150 FROM C$142
- EQB INC. <EQB.TO>: RAYMOND JAMES RAISES TARGET PRICE TO C$136 FROM C$123
- Bradespar 2Q FY26 net profit drops 43.9% to R$ 252.31 million
- Accelerant FY26 Q2 net income rises to $80 million; revenue climbs 63% to $356.9 million
- McGraw Hill Backs FY27 Rev $2.115B-$2.175B >MH
- McGraw Hill 1Q Adj EPS 59c >MH
- NG Energy: Combined Avg Daily Net Production for Sale of 14.222 Mcf/d In 2Q >GASX.T
- NG Energy 2Q Natural Gas and NGL Sales $10.8M >GASX.T
- McGraw Hill 1Q Rev $549.9M >MH
- AXOS FINANCIAL, INC. : BENCHMARK RAISES TARGET PRICE TO $120 FROM $115
- Zenas Biopharma posts corporate presentation on autoimmune disease pipeline, led by obexelimab program
- DEFINIUM THERAPEUTICS INC <DFTX.O>: JONESTRADING RAISES TARGET PRICE TO $90 FROM $74
- CuriosityStream Shares Gain on Higher Outlook After Income, Revenue Rise
- Venu Holding 6-Mos Loss/Shr 60c >VENU
- Venu Holding 6-Mos Rev $8.5M >VENU
- VIKING HOLDINGS LTD <VIK.N>: STIFEL RAISES TARGET PRICE TO $125 FROM $105
- ALPHA AND OMEGA SEMICONDUCTOR LIMITED : NEEDHAM CUTS TARGET PRICE TO $45 FROM $50
- LB PHARMACEUTICALS INC <LBRX.O>: STIFEL RAISES TARGET PRICE TO $53 FROM $40
- OrizonVR buys 51% stake in Rondonópolis sanitary landfill for R$ 45.4 million
- Banrisul cuts 2026 net interest income growth outlook to 5%-10%
- NG Energy reports C$ 26.51 million warrant exercises as unexercised warrants expire
- Avai Bio Q1 FY27 net loss widens 13% to $552,041; revenue remains no revenue
- BRINKER INTERNATIONAL INC <EAT.N>: RAYMOND JAMES RAISES TARGET PRICE TO $270 FROM $210
- POLARYX THERAPEUTICS, INC : RAYMOND JAMES INITIATES COVERAGE WITH STRONG BUY RATING; TARGET PRICE $6
- Nam Cheong 1H FY26 net profit rises 82.9% YoY to RM 164.4 million; revenue climbs 25.2% to RM 348.3 million
- HORACE MANN EDUCATORS CORP <HMN.N>: RAYMOND JAMES RAISES TARGET PRICE TO $59 FROM $53
- APPLIED AEROSPACE & DEFENSE INC : MORGAN STANLEY RAISES TARGET PRICE TO $24.00 FROM $23.00
- CEREBRAS SYSTEMS <CBRS.O>: MORGAN STANLEY RAISES TARGET PRICE TO $279.00 FROM $273.00
- GROCERY OUTLET HOLDING CORP <GO.O>: MORGAN STANLEY RAISES TARGET PRICE TO $11.00 FROM $7.00
- Calian Q3 FY26 revenue hits record as company cites organic growth in Defence & Space, Essential Industries
- McGraw Hill FY27 Q1 net income turns to profit at $57.86 million; revenue rises 2.6% to $549.9 million
- Alithya turns to FY27 Q1 net loss of CAD 2.4 million; revenue drops 15.4% to CAD 105.1 million
- EROCK <EROC.N>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $19.00 FROM $16.00
- Pelthos Therapeutics 2Q Loss/Shr $6.62 >PTHS
- Arcos Dorados FY26 Q2 net income more than doubled to USD 45 million; revenue rises 14.3% to USD 1.31 billion
- Liminatus Pharma moves Nasdaq listing to Capital Market tier
- SES AI appoints Generac engineering executive Paul Diemer to board
- Mobix Labs signs deal to acquire rare earth supply-chain platform Special Project Delivery in all-stock transaction
- Cellectar Biosciences 2Q Loss/Shr 57c >CLRB
- Cellectar Biosciences 2Q Loss $6.93M >CLRB
- XRP Fails to Recover, Recording Lowest Daily Close Since November 2024! Here’s Why
- Monero Price Prediction: XMR Bulls Target $415 as FCMP++ Stressnet Advances
- Lensar 2Q Net $3.54M >LNSR
- American Shared Hospital 2Q Rev $8.43M >AMS
